Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events (original) (raw)

Cardiovascular Issues in Hypogonadism and Testosterone Therapy

The American Journal of Cardiology, 2005

Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)

Glenn Cunningham

International journal of clinical practice, 2016

View PDFchevron_right

Testosterone and cardiovascular disease - the controversy and the facts

Neil Baum

Postgraduate medicine, 2015

View PDFchevron_right

TESTOSTERONE REPLACEMENT THERAPY: ASSESSMENT OF CARDIOVASCULAR RISKS (Atena Editora)

Atena Editora

TESTOSTERONE REPLACEMENT THERAPY: ASSESSMENT OF CARDIOVASCULAR RISKS (Atena Editora), 2024

View PDFchevron_right

TESTOSTERONE REPLACEMENT THERAPY IN MEN WITH HYPOGONADISM AND CARDIOVASCULAR RISK: A SYSTEMATIC REVIEW (Atena Editora)

Atena Editora

TESTOSTERONE REPLACEMENT THERAPY IN MEN WITH HYPOGONADISM AND CARDIOVASCULAR RISK: A SYSTEMATIC REVIEW (Atena Editora), 2024

View PDFchevron_right

Testosterone and Cardiovascular Health

Felice Gersh

Mayo Clinic proceedings, 2018

View PDFchevron_right

Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study

Giuseppe M C Rosano

Vascular health and risk management, 2016

View PDFchevron_right

Testosterone therapy and cardiovascular risk

Monica Caliber

Trends in cardiovascular medicine, 2014

View PDFchevron_right

State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males

ahmed elsherbiny

Current Cardiology Reports, 2017

View PDFchevron_right

Deaths and Cardiovascular Events in Men Receiving Testosterone

Paresh Dandona

JAMA, 2014

View PDFchevron_right

Testosterone and cardiovascular disease

Thomas Jones

Current Opinion in Endocrinology & Diabetes and Obesity, 2014

View PDFchevron_right

The Inverse Association between Testosterone Replacement Therapy and Cardiovascular Disease Risk: A Systematic 25-year Review and Meta-Analysis Analysis of Prospective Cohort Studies from 1999 to 2024

Julian Borges MD

International Journal of Cardiovascular Medicine, 3(4), 2024

View PDFchevron_right

Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure

Cesare Sirtori

Reviews in Endocrine and Metabolic Disorders, 2021

View PDFchevron_right

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease

Martin Miner

Asian Journal of Andrology, 2015

View PDFchevron_right

Is testosterone treatment dangerous for the cardiovascular system in older hypogonadal men?

Antonio Aversa

View PDFchevron_right

The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials

Alvin Matsumoto

The Journal of Clinical Endocrinology and Metabolism, 2017

View PDFchevron_right

Testosterone Therapy and Cardiovascular Risk: Advances and Controversies

Monica Caliber

Mayo Clin Proc. 2015;90(2):224-251

View PDFchevron_right

Testosterone: Friend or foe for the cardiovascular system in men?

Ana Elida Ciobanu

Annals of Clinical and Analytical Medicine, 2020

View PDFchevron_right

Exogenous Testosterone, Cardiovascular Events, and Cardiovascular Risk Factors in Elderly Men: A Review of Trial Data

Giuseppe M C Rosano

The Journal of Sexual Medicine, 2011

View PDFchevron_right

Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations

Carolyn Allan

The Medical Journal of Australia, 2016

View PDFchevron_right

Cardiovascular effect of testosterone replacement therapy in aging male

Antonio Aversa

View PDFchevron_right

Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system

Thomas Jones

Asian journal of andrology

View PDFchevron_right

The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk

Martin Miner

Clinical Endocrinology, 2018

View PDFchevron_right

Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System

Viet Y Huynh Le

The American journal of cardiology, 2015

View PDFchevron_right

The Effect of Testosterone on Cardiovacular Biomarkers in the Testosterone Trials

Glenn Cunningham

The Journal of clinical endocrinology and metabolism, 2017

View PDFchevron_right

Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis

Elisa Maseroli

Expert Opinion on Drug Safety, 2014

View PDFchevron_right

Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease

Jeffrey Probstfield

American Heart Journal, 2020

View PDFchevron_right

Effects of Testosterone Therapy on Cardiovascular Risk Markers in Androgen-Deficient Women with Hypopituitarism

Gary Bradwin

The Journal of Clinical Endocrinology & Metabolism, 2007

View PDFchevron_right

Low serum testosterone and increased mortality in men with coronary heart disease

saifullah asif

Heart, 2010

View PDFchevron_right

Welcoming low testosterone as a cardiovascular risk factor

Marcello Maggio

International Journal of Impotence Research, 2009

View PDFchevron_right

Association Between Testosterone Treatment and Risk of Incident Cardiovascular Events Among US Male Veterans With Low Testosterone Levels and Multiple Medical Comorbidities

Anna Korpak

Journal of the American Heart Association

View PDFchevron_right

Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring

Ernani Rhoden

New England Journal of Medicine, 2004

View PDFchevron_right

The effect of testosterone replacement on endothelial dysfunction, inflammation and insulin resistance in male hypogonadotrophic hypogonadism

TANER OZGURTAS

Endocrine Abstracts, 2013

View PDFchevron_right

Testosterone therapy and mortality risk

Ludfiana kurnianti

International journal of impotence research, 2015

View PDFchevron_right

Effects of Testosterone Undecanoate on Cardiovascular Risk Factors and Atherosclerosis in Middle��Aged Men with Late��Onset Hypogonadism and Metabolic Syndrome: Results from a 24��month, Randomized, Double��Blind, Placebo��Controlled Study

Giuseppe M C Rosano

2010

View PDFchevron_right

Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events (original) (raw)

Related papers